Manuela Albertelli Selected Research

Manuela Albertelli Research Topics

Disease

18	Neoplasms (Cancer) 03/2024 - 04/2007
12	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 03/2013
3	Type 2 Diabetes Mellitus (MODY) 03/2024 - 02/2010
3	Pituitary Neoplasms (Pituitary Adenoma) 08/2019 - 04/2007
3	Cushing Syndrome 04/2017 - 01/2010
2	medullary Thyroid cancer 09/2023 - 01/2021
2	Disease Progression 08/2023 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 08/2023 - 06/2006
2	Carcinoid Tumor (Carcinoid) 06/2023 - 04/2017
2	Carcinogenesis 09/2021 - 01/2014
2	Primitive Neuroectodermal Tumors (PNET) 06/2017 - 10/2014
1	Thyroid Nodule (Nodule, Thyroid) 09/2023
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 05/2023
1	Thyroid Neoplasms (Thyroid Cancer) 02/2022
1	Insulinoma 11/2020
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Gallstones (Gallstone) 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Acromegaly 01/2019
1	Cholelithiasis 09/2017
1	Fatigue 09/2017
1	Metaplasia 06/2017
1	Atrophic Gastritis 06/2017
1	Polyuria 12/2015
1	Diabetes Insipidus 12/2015
1	Nephrogenic Diabetes Insipidus 12/2015
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 12/2015
1	Inflammation (Inflammations) 01/2014
1	Infections 01/2014
1	Prolactinoma (Prolactinomas) 04/2007
1	Adenoma (Adenomas) 04/2007
1	Carcinoma (Carcinomatosis) 12/2005
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2005

Drug/Important Bio-Agent (IBA)

7	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2021 - 12/2005
4	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2023 - 01/2010
3	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 12/2005
3	Hormones (Hormone)IBA 01/2021 - 04/2007
3	pasireotideIBA 11/2020 - 10/2014
3	Somatostatin Receptors (Somatostatin Receptor)IBA 08/2019 - 01/2010
3	Dopamine Receptors (Dopamine Receptor)IBA 01/2010 - 12/2005
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 09/2023 - 01/2021
2	LigandsIBA 08/2019 - 01/2019
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2019 - 04/2007
2	Octreotide (Sandostatin)FDA LinkGeneric 06/2017 - 10/2014
2	Chromogranin AIBA 06/2017 - 10/2014
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 03/2013 - 01/2010
1	Metformin (Glucophage)FDA LinkGeneric 03/2024
1	CalciumIBA 09/2023
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 08/2023
1	Vitamin D FDA LinkGeneric 08/2023
1	hydroxide ionIBA 08/2023
1	Peptides (Polypeptides)IBA 06/2023
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 06/2023
1	17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)IBA 05/2023
1	Phosphotransferases (Kinase)IBA 02/2022
1	ChromatinIBA 09/2021
1	thiazolyl blueIBA 01/2021
1	lanreotide (Somatuline)FDA Link 01/2021
1	FITC-annexin A5IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Propidium (Propidium Iodide)IBA 01/2021
1	Diazoxide (Hyperstat)FDA Link 11/2020
1	IncretinsIBA 03/2020
1	SodiumIBA 01/2020
1	Growth Hormone (Somatotropin)IBA 01/2019
1	enhanced green fluorescent proteinIBA 08/2017
1	3,3'- dioactadecyl- 5,5'- di(4- sulfophenyl)oxacarbocyanineIBA 08/2017
1	Everolimus FDA Link 06/2017
1	TOR Serine-Threonine KinasesIBA 06/2017
1	ParaffinIBA 01/2016
1	Vasopressins (Vasopressin)IBA 12/2015
1	Peptide Receptors (Peptide Receptor)IBA 01/2015
1	ChemokinesIBA 01/2014
1	Technetium (Technetium 99m)IBA 02/2010
1	Dopamine Agents (Dopaminergic Agents)IBA 04/2007
1	Analgesics (Analgesic Drugs)IBA 06/2006

Therapy/Procedure

7	Therapeutics 03/2020 - 04/2007
1	Lymph Node Excision (Lymph Node Dissection) 11/2022
1	Drug Therapy (Chemotherapy) 01/2021
1	Immunotherapy 01/2021
1	Colectomy 01/2020
1	Appendectomy 01/2020
1	Biological Therapy 01/2015
1	Radiotherapy 04/2007